Delivery Order 36C25022D0001-36C25025N0015

Award Date 10/1/24
Potential Completion Date 9/30/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $163,389.90 firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Ortho-Clinical Diagnostics, Inc. The contract is for pathology and laboratory services and is not set aside for any particular business type. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions, including the QuickVue At HomeTM COVID-19 Test and VITROS...
This is a modification to a delivery order contract (VA24116J0707) held by Ortho-Clinical Diagnostics, Inc. to provide blood bank cells and reagents to the U.S. Department of Veterans Affairs (VA). The original contract had a ceiling value of $97,175.15 and was awarded on February 25, 2016 with a period of performance through March 29, 2018. The contract is a firm fixed price vehicle and was not set aside for any socioeconomic program. Ortho-Clinical Diagnostics is a for-profit medical equipment...
This is a firm fixed price delivery order awarded to Ortho-Clinical Diagnostics, Inc. by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs. The order, valued at $102,030.72, is for pathology and laboratory services under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) schedule contract. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions, including the...
This is a Firm Fixed Price delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturing company. The $210,341.08 contract provides "cost per test" services under the Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III). Ortho-Clinical Diagnostics has provided diagnostic solutions, including COVID-19 tests and immunodiagnostic/chemistry analyzers, to...
This is a delivery order awarded by the Veterans Integrated Service Network 22 (VISN 22), a civilian agency within the Department of Veterans Affairs, to Ortho-Clinical Diagnostics, Inc. The $1,594,141.70 firm fixed-price contract is for the delivery of a dry chemistry immunochemistry system. The contract has a period of performance ending on March 31, 2025 and was awarded on April 1, 2024. This order is part of Ortho-Clinical Diagnostics' existing indefinite-delivery/indefinite-quantity...
This is a $9,310,931.34 firm-fixed-price delivery order contract awarded to Ortho-Clinical Diagnostics, Inc. by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 22. The contract provides critical laboratory analyzers, reagents, and related services to support federal healthcare programs. Ortho-Clinical Diagnostics is a medical equipment manufacturer that offers a range of diagnostic solutions. The contract is not set aside and is awarded under the General Services...
This federal contract award was made by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturing company. The $359,237.35 Delivery Order contract is for Critical Analyzers, Laboratory (FSS-66-III) under the VA VHA's Veterans Integrated Service Network 23. Ortho-Clinical Diagnostics provides a range of diagnostic solutions, including the QuickVue At Home COVID-19 Test and VITROS immunodiagnostic and clinical...
This federal contract award is for a DRY CHEMISTRY/IMMUNOCHEMISTRY SYSTEM for the Veterans Integrated Service Network 22, a civilian agency under the U.S. Department of Veterans Affairs. The $1,350,026.57 firm fixed price delivery order was awarded to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, on August 12, 2024. The contract has an ultimate completion date of April 14, 2027. Ortho-Clinical Diagnostics has provided medical equipment, reagents, consumables, and testing...
This is a $1,249,908.74 firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 22, a civilian agency under the Department of Veterans Affairs, to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The contract is for the delivery of a dry chemistry/immunochemistry system and associated products and services, with a period of performance ending on August 11, 2024. Ortho-Clinical Diagnostics, Inc. is a provider of advanced diagnostic...
This is a federal contract award to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturer and supplier, by the Veterans Integrated Service Network 16, a civilian agency of the U.S. Department of Veterans Affairs. The contract is for the delivery of medical equipment, specifically clinical chemistry analyzers, immunoassay systems, blood typing instruments, and related reagents and consumables. The contract is a Delivery Order under the Critical Analyzers, Laboratory (FSS-66-III)...
  • 36C25022D0001
    Indefinite Delivery Contract
  • 36C25022D0001-36C25025N0015
    Delivery Order

This is a modification to a delivery order contract awarded to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, by the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs. The modification adds line item descriptions for a supply chain master catalogue. The base contract is a firm-fixed-price instrument with a potential value of $17,319.97 and a completion date of September 30, 2025. Ortho-Clinical Diagnostics has provided a range of diagnostic solutions, including COVID-19 tests and immunodiagnostic analyzers, to various federal agencies through indefinite-delivery/indefinite-quantity contracts and other contract vehicles. This modification is not associated with a set-aside designation.

Generated 1/9/25, 9:19 AM